CoChat
Sign Up
Cited by 161

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The γ-Secretase Complex: Membrane-Embedded Proteolytic Ensemble

Wolfe, Michael S.·2006·Biochemistry
DOI 10.1021/bi060799c
Open this paper in CoChat — free account

Abstract

Gamma-secretase is responsible for the proteolytic processing of a variety of membrane-associated fragments derived from type I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor. This enzyme is composed of four different integral membrane proteins: presenilin, nicastrin, Aph-1, and Pen-2. During assembly and maturation of the protease complex, presenilin is endoproteolyzed into two subunits, each of which contributes one aspartate to the active site of an aspartyl protease. Substrate apparently interacts with an initial docking site before passing in whole or in part between the two presenilin subunits to the internal water-containing active site. The ectodomain of nicastrin also interacts with the N-terminus of the substrate as an essential step in substrate recognition and processing. Sites for allosteric regulation on the protease complex allow selective inhibition or modulation of APP processing without interfering with Notch signaling, and such selective agents may represent promising leads for the development of Alzheimer's disease therapeutics. Elucidation of detailed structural features of gamma-secretase and other membrane-embedded proteases is the next frontier in understanding how these enzymes carry out hydrolysis within the lipid bilayer.

Overview

Integrity signals

Registry

Crossref · 10.1021/bi060799c

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • γ-secretase is a multiprotein complex consisting of redundant catalytic and regulatory subunits, as well as unique targeting (Nicastrin) and enhancer (PEN2) components that regulate intramembrane proteolysis of Type 1 transmembrane proteins.

    “The γ-secretase is a multiprotein complex consisting of redundant catalytic (Presenilin 1 or 2) and regulatory (Aph-1a or -1b) subunits, as well as unique targeting (Nicastrin) and enhancer (PEN2) components that regulate intramembrane proteolysis of Type 1 transmembrane proteins (Wolfe, 2006).”

    From γ-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor (2018) · cites this paper as Wolfe, 2006

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 103

  1. Glenner G. G., 1984, Biochem. Biophys. Res. Commun. 120, 885−90.
  2. Selkoe D. J., 2001, Physiol. Rev., 81, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
  3. Hardy J., 1997, Trends Neurosci. 20, 154−9.
  4. Citron M., 1992, Nature 360, 672−4.
  5. Cai X. D., 1993, Science 259, 514−6.
  6. Suzuki N., 1994, Science 264, 1336−40.
  7. Roher A. E., 1993, Proc. Natl. Acad. Sci. U.S.A. 90
  8. Sherrington R., 1995, Nature 375, 754−60.
  9. Levy-Lahad E., 1995, Science 269, 973−7.
  10. Rogaev E. I., 1995, Nature 376, 775−8.
  11. L'Hernault S. W., 1992, J. Cell Biol., 119, 68, 10.1083/jcb.119.1.55 · DOI
  12. Scheuner D., 1996, 2, 864−70.
  13. Duff K., 1996, Nature 383, 710−3.
  14. Lemere C. A., 1996, 2, 1146−50.
  15. Tanzi R. E., 2005, Cell 120, 545−55.
  16. De Strooper B., 1998, Nature 391, 387−90.
  17. Artavanis-Tsakonas S., 1999, Science 284, 770−6.
  18. Levitan D., 1995, Nature 377, 351−4.
  19. Schroeter E. H., 1998, Nature 393, 382−6.
  20. Wong P. C., 1997, Nature 387, 288−92.
  21. Shen J., 1997, Cell 89, 629−39.
  22. De Strooper B., 1999, Nature 398, 518−22.
  23. Kim J., 2004, Proc. Natl. Acad. Sci. U.S.A. 101
  24. Li X., 1996, Neuron 17, 1015−21.
  25. Li X., 1998, Proc. Natl. Acad. Sci. U.S.A. 95
  26. Doan A., 1996, Neuron 17, 1023−30.
  27. Laudon H., 2005, J. Biol. Chem., 280, 10.1074/jbc.M507217200 · DOI
  28. Oh Y. S., 2005, Biochemistry 44, 11821−8.
  29. Thinakaran G., 1996, Neuron 17, 181−90.
  30. Ratovitski T., 1997, J. Biol. Chem., 272, 10.1074/jbc.272.39.24536 · DOI
  31. Thinakaran G., 1997, J. Biol. Chem., 272, 10.1074/jbc.272.45.28415 · DOI
  32. Wolfe M. S., 1999, Biochemistry 38, 4720−7.
  33. Shearman M. S., 2000, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity, Biochemistry 39, 8698−704.
  34. Wolfe M. S., 1999, Nature 398, 513−7.
  35. Wolfe, M. S., De Los Angeles, J., Miller, D. D., Xia, W., and Selkoe, D. J. (1999) Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease,Biochemistry38, 11223−30. · DOI
  36. Li Y. M., 2000, Nature 405, 689−94.
  37. Esler W. P., 2000, Nat. Cell Biol. 2, 428−34.
  38. Capell A., 1998, J. Biol. Chem., 273, 10.1074/jbc.273.6.3205 · DOI
  39. Yu G., 1998, J. Biol. Chem., 273
  40. Weihofen A., 2002, Science 296, 2215−8.
  41. Kang D., 2002, Cell, 110, 751, 10.1016/S0092-8674(02)00970-4 · DOI
  42. Baki L., 2004, EMBO J., 23, 10.1038/sj.emboj.7600251 · DOI
  43. Huppert S. S., 2005, Dev. Cell 8, 677−88.
  44. Song W., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
  45. Bentahir M., 2006, J. Neurochem., 96, 10.1111/j.1471-4159.2005.03578.x · DOI
  46. Weidemann A., 2002, Biochemistry 41, 2825−35.
  47. Sato T., 2003, J. Biol. Chem., 278
  48. Yu G., 2000, Nature, 407, 54
  49. Esler W. P., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
  50. Edbauer D., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
  51. Arawaka S., 2002, J. Neurochem., 83, 10.1046/j.1471-4159.2002.01207.x · DOI
  52. Kimberly W. T., 2002, J. Biol. Chem., 277, 10.1074/jbc.M204446200 · DOI
  53. Leem J. Y., 2002, J. Biol. Chem., 277
  54. Tomita T., 2002, FEBS Lett. 520, 117−21.
  55. Goutte C., 2000, Development 127, 2481−92.
  56. Li T., 2003, J. Neurosci., 23
  57. Francis R., 2002, Dev. Cell, 3, 97, 10.1016/S1534-5807(02)00189-2 · DOI
  58. Takasugi N., 2003, Nature 422, 438−41.
  59. Kimberly W. T., 2003, Proc. Natl. Acad. Sci. U.S.A. 100
  60. Edbauer D., 2003, Nat. Cell Biol. 5, 486−8.
  61. Fraering P. C., 2004, Biochemistry 43, 9774−89.
  62. Shah S., 2005, Cell 122, 435−47.
  63. Zhou S., 2005, Proc. Natl. Acad. Sci. U.S.A. 102
  64. Lazarov V. K., 2006, Proc. Natl. Acad. Sci. U.S.A. 103
  65. Schroeter E. H., 2003, Proc. Natl. Acad. Sci. U.S.A. 100
  66. Hebert S. S., 2003, Biochem. Biophys. Res. Commun. 301, 119−26.
  67. Cervantes S., 2004, J. Biol. Chem., 279, 10.1074/jbc.M404832200 · DOI
  68. Nyborg A. C., 2004, J. Biol. Chem., 279
  69. Kopan R., 2004, Nat. Rev. Mol. Cell Biol., 5, 10.1038/nrm1406 · DOI
  70. Lai M. T., 2003, J. Biol. Chem., 278
  71. Gu Y., 2002, J. Biol. Chem., 278
  72. LaVoie M. J., 2003, J. Biol. Chem., 278
  73. Luo W. J., 2003, J. Biol. Chem., 278
  74. Fraering P. C., 2004, Biochemistry 43, 323−33.
  75. Watanabe N., 2005, J. Biol. Chem., 280
  76. Kim S. H., 2005, J. Biol. Chem., 280
  77. Capell A., 2003, J. Biol. Chem., 278, 10.1074/jbc.C300435200 · DOI
  78. Fortna R. R., 2004, J. Biol. Chem., 279, 10.1074/jbc.M310505200 · DOI
  79. Crystal A. S., 2003, J. Biol. Chem., 278, 10.1074/jbc.M213107200 · DOI
  80. Mackinnon R., 2005, Science 307, 1425−6.
  81. Annaert W. G., 2001, Neuron 32, 579−89.
  82. Brunkan A. L., 2005, J. Neurochem., 94, 10.1111/j.1471-4159.2005.03278.x · DOI
  83. Kornilova A. Y., 2006, Biochemistry 45, 7598−7604.
  84. Saura C. A., 2000, J. Biol. Chem., 275, 10.1074/jbc.M909624199 · DOI
  85. Podlisny M. B., 1997, Neurobiol. Dis. 3, 325−37.
  86. Laudon H., 2004, J. Biol. Chem., 279, 10.1074/jbc.M401277200 · DOI
  87. Tomita T., 1999, J. Neurosci., 19, 10.1523/JNEUROSCI.19-24-10627.1999 · DOI
  88. Kaether C., 2004, EMBO J., 23, 10.1038/sj.emboj.7600478 · DOI
  89. Das C., 2003, J. Am. Chem. Soc., 125
  90. Kornilova A. Y., 2005, Proc. Natl. Acad. Sci. U.S.A. 102
  91. Bihel F., 2004, J. Med. Chem., 47, 10.1021/jm049788c · DOI
  92. Searfoss G. H., 2003, J. Biol. Chem., 278, 10.1074/jbc.M307757200 · DOI
  93. Wong G. T., 2004, J. Biol. Chem., 279
  94. Weggen S., 2001, Nature 414, 212−6.
  95. Weggen S., 2003, J. Biol. Chem., 278
  96. Beher D., 2004, J. Biol. Chem., 279, 10.1074/jbc.M404937200 · DOI
  97. Okochi M., 2006, J. Biol. Chem., 281, 10.1074/jbc.M513250200 · DOI
  98. Sato T., 2006, Biochemistry 45 (in press).
  99. Netzer W. J., 2003, Proc. Natl. Acad. Sci. U.S.A. 100
  100. Fraering P. C., 2005, J. Biol. Chem., 280, 10.1074/jbc.M501368200 · DOI
  101. Wolfe M. S., 2004, Science 305, 1119−23.
  102. Goutte C., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
  103. Abbreviations Aβ, amyloid β-protein

Cited by

Sorted by citations

Metadata

Authors
Wolfe, M. S.
Affiliations
Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115
Venue
Biochemistry
Publisher
American Chemical Society (ACS)
Published
2006-06-10
Volume
45
Issue
26
Pages
7931-7939
ISSN
  • 0006-2960
  • 1520-4995
DOI
10.1021/bi060799c
Cited by
161
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review